Altre lingue Wuhan Keqian Biology Co.,Ltd

Azioni

688526

CNE1000042Q8

Prodotti farmaceutici

Prezzo di chiusura Shanghai S.E. Altri mercati azionari 10/01/2025			Variaz. 5gg	Var. 1 gen.
12,58 ^CNY	-2,56%		-6,61%	-11,97%

30/10	Wuhan Keqian Biology Co.,Ltd riporta i risultati degli utili per i nove mesi conclusi il 30 settembre 2024	CI
11/10	Wuhan Keqian Biology ottiene l'approvazione cinese per il vaccino contro la pseudorabbia	MT

Altre lingue

Tranche Update on Wuhan Keqian Biology Co.,Ltd's Equity Buyback Plan announced on February 22, 2024.	03/01
Wuhan Keqian Biology Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2024	30/10/24
Wuhan Keqian Biology Gets China Approval for Pseudorabies Vaccine	11/10/24
Tranche Update on Wuhan Keqian Biology Co.,Ltd's Equity Buyback Plan announced on February 22, 2024.	09/10/24
Certain A Shares of Wuhan Keqian Biology Co.,Ltd are subject to a Lock-Up Agreement Ending on 22-SEP-2024.	22/09/24
Wuhan Keqian Biology Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2024	29/08/24
Tranche Update on Wuhan Keqian Biology Co.,Ltd's Equity Buyback Plan announced on February 22, 2024.	02/07/24
Wuhan Keqian Biology Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	29/04/24
Tranche Update on Wuhan Keqian Biology Co.,Ltd's Equity Buyback Plan announced on February 22, 2024.	02/04/24
Wuhan Keqian Biology Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	26/02/24
Wuhan Keqian Biology Co.,Ltd announces an Equity Buyback for CNY 50 million worth of its shares.	22/02/24
Wuhan Keqian Biology Co.,Ltd authorizes a Buyback Plan.	20/02/24
Wuhan Keqian Biology Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	26/10/23
Certain A Shares of Wuhan Keqian Biology Co.,Ltd are subject to a Lock-Up Agreement Ending on 22-SEP-2023.	22/09/23
Wuhan Keqian Biology Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	28/08/23
Wuhan Keqian Biology Elects Chairman, Vice Chairman	06/07/23
Wuhan Keqian Biology Co.,Ltd cancelled the transaction announced on October 28, 2022	26/06/23
Wuhan Keqian Biology Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	17/04/23
Wuhan Keqian Biology Co.,Ltd announces decision of Shareholder/Board on the transaction	18/11/22
Wuhan Keqian Biology’s New Swine Vaccines Obtain Registration Certificates in China	10/11/22
Wuhan Keqian Biology Partners With University for Vaccine Development	03/11/22
Wuhan Keqian Biology Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022	28/10/22
Wuhan Keqian Biology Co.,Ltd announced a financing transaction	28/10/22
Certain A Shares of Wuhan Keqian Biology Co.,Ltd are subject to a Lock-Up Agreement Ending on 22-SEP-2022.	22/09/22
Wuhan Keqian Biology Co.,Ltd(XSSC:688526) added to S&P Global BMI Index	19/09/22

Iscriviti per accedere a più notizie

Registrazione 100% gratuita

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Wuhan Keqian Biology Co.,Ltd

Azioni

688526

CNE1000042Q8

Prodotti farmaceutici

Altre lingue

Filtri